Long-lasting remission in a metastatic hepatocellular carcinoma patient after combined regorafenib therapy and surgery

AIMS: The therapeutic scenario of systemic treatments for hepatocellular carcinoma (HCC) is rapidly changing. There is much interest in the possibility of combining new therapies with surgery, but clinical data is lacking. We aimed to provide an example of such integration. PATIENTS & METHODS: W...

Descripción completa

Detalles Bibliográficos
Autores principales: Goio, Elisabetta, Ielasi, Luca, Benevento, Francesca, Renzulli, Matteo, Tovoli, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2020
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399611/
https://www.ncbi.nlm.nih.gov/pubmed/32774834
http://dx.doi.org/10.2217/hep-2020-0014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399611/
https://www.ncbi.nlm.nih.gov/pubmed/32774834
http://dx.doi.org/10.2217/hep-2020-0014

Ejemplares similares